Should There Be a War on Cancer? Certainly Not, Because the Enemy is “Us” - Keynote Address on April 22
speaker for the School of Health and Medical Sciences' 25th
Anniversary Dr. George Perez Research Colloquium will be Dr. Arnold D. Rubin, MD.
His keynote presentation, titled "Should There Be a War on Cancer? Certainly
Not, Because the Enemy is 'Us'", will take place on Tuesday, April 22, at 10:15 a.m. in the Field House within the Richie
Regan Recreation Center on the South Orange Campus. All are welcome to attend.
Light refreshments will be provided at the conclusion of his talk.
Should There Be a War on
Cancer? Certainly Not, Because the Enemy is "Us"
as a disease, carries with it considerable baggage, some scientific, but much
emotional and political. It has been described in a military metaphor as a war
against a dreaded enemy. Dr. Rubin will attempt to convince you that such a
metaphor does not serve us well, for cancer is inexorably associated with life
on this planet and is a biologic result of evolution.
there may be specifically avoidable provoking forces, cancer is ultimately a
function of chance, involving genes adapting to an ever-changing environment.
The longer one lives, the more likely cancer will develop. Therapy, for
generations, has been directed at cutting out or otherwise destroying living
cells. But recent developments have suggested that the altered gene function
can be addressed and managed and the immune system can be harnessed to prolong
useful and productive existence.
By stripping away emotional and political reactions to
cancer from its existential threat, we can begin to cope with the uncertainty
and anxiety regarding less than clear-cut choices.
D. Rubin, MD
Dr. Rubin is a renowned
scholar in the treatment of hematologic malignancies. He received a BA degree
from Harvard University and an MD degree from New York University School of
Medicine, where he studied immunology on a pre-doctoral fellowship before
graduation. He did his clinical training at Yale-New Haven Medical Center and a
hematology fellowship at the Tufts-New England Medical Center.
Dr. Rubin's research career
continued at the National Institutes of Health, where he was part of the early
development of cellular immunology and lymphocyte research. He continued this
work at the Mount Sinai School of Medicine before coming to St. Joseph's
Regional Medical Center in Paterson, New Jersey, as Chair of the Department of
Medicine and Director of the Hematology Oncology Division. At St. Joseph's, he
created the first bone marrow transplant unit and leukemia treatment center in
For the past 12 years, he directed the bone marrow
transplant program at the Rutgers Cancer Institute of New Jersey as Professor
of Medicine, Division of Medical Oncology, at Rutgers Robert Wood Johnson
Medical School. He has been active in teaching students, residents and fellows
for 50 years and is the author of more than 70 original publications, reviews
and book chapters and numerous national and international presentations.
The School of Health and Medical Sciences' 25th Anniversary Dr. George Perez Research Colloquium, presented in conjunction with the Seton Hall University Petersheim Academic Exposition, will take place on Tuesday, April 22, from 7:30 a.m. to 1 p.m. in the Field House. The Research Colloquium, which features more than 230 poster and oral presentations as well as Dr. Rubin's keynote address, is sponsored by MDAdvantage Insurance Company of New Jersey, a leading provider of medical professional liability insurance in the state.
For more information please contact: